Type 1 interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite

Immunity

Volumn 8, Issue 1, 1998, Pages 77-87

  Diefenbach, Andreas ^a   Schindler, Heike ^a   Donhauser, Norbert ^a   Lorenz, Elke ^a   Laskay, Tamás ^a   MacMicking, John ^b,d   Röllinghoff, Martin ^a   Gresser, Ion ^c   Bogdan, Christian ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c CNRS   (France)

^d ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENZYME ACTIVITY; ENZYME INDUCTION; GENE DELETION; HOST RESISTANCE; HOST SUSCEPTIBILITY; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL;

EID: 0031907920     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80460-4     Document Type: Article

References (47)

1. Beckerman, K.P., Rogers, H.W., Corbett, J.A., Schreiber, R.D., McDaniel, M.L., and Unanue, E.R. (1993). Release of nitric oxide during the T cell-independent pathway of macrophage activation. J. Immunol. 150, 888-895.
2. Belardelli, F., and Gresser, I. (1996). The neglected role of type I interferon in the T cell response: implications for its clinical use. Immunol. Today 17, 369-372.
3. Biron, C.A., and Gazzinelli, R.T. (1995). Effects of IL-12 in immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7, 485-496.
4. Bogdan, C. (1997). Of microbes, macrophages and NO. Behring Inst. Res. Commun. 99, 58-72.
5. Bogdan, C., Stenger, S., Röllinghoff, M., and Solbach, W. (1991). Cytokine interactions in experimental cutaneous leishmaniasis: interleukin 4 synergizes with interferon-γ to activate murine macrophages for killing of Leishmania major amastigotes. Eur. J. Immunol. 21, 327-333.
6. Cifone, M.G., Festuccia, C., Cironi, L., Cavallo, G., Chessa, M.A., Pensa, V., Tubaro, E., and Santoni, A. (1994). Induction of the nitric oxide-synthesizing pathway in fresh and interleukin-2 cultured rat natural killer cells. Cell. Immunol. 157, 181-194.
7. Danielpour, D. (1993). Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor-β1. J. Immunol. Meth. 158, 17-25.
8. De Maeyer-Guignard, J., Dandoy, F., Bailey, D.W., and De Maeyer, E. (1986). Interferon structural genes do not participate in quantitative regulation of interferon production by lf loci as shown in C57BL/6 mice that are congenic with BALB/c mice at the alpha interferon gene cluster. J. Virol. 58, 743-747.
9. Derynck, R., Jarrett, J.A., Chen, E.Y., and Goeddel, D.V. (1986). The murine transforming growth factor-β precursor. J. Biol. Chem. 261, 4377-4379.
10. Ding, A.H., Nathan, C.F., and Stuehr, D.J. (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141, 2407-2412.
11. Duncan, G.S., Mittrücker, H.-W., Kägi, D., Matsuyama, T., and Mak, T.W. (1996). The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J. Exp. Med. 184, 2043-2048.
12. Evans, T.G., Thai, L., Granger, D.L., and Hibbs, J.B., Jr. (1993). Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151, 907-915.
13. Förster, E. (1994). An improved general method to generate internal standards for competitive PCR. Biotechniques 16, 18-20.
14. Gresser, I., Maury, C., Vignaux, F., Haller, O., Belardelli, F., and Tovey, M.G. (1988). Antibody to mouse interferon α/β abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice. J. Exp. Med. 168, 1271-1291.
15. Havell, E.A. (1993). Listeria monocytogenes-induced interferon-γ primes the host for production of tumor necrosis factor and interferon-α/β. J. Infect. Dis. 1993, 1364-1371.
16. Juretic, A., Spagnoli, G.C., von Bremen, K., Hörig, H., Filgueira, L., Lüscher, U., Babst, R., Harder, F., and Heberer, M. (1994). Generation of lymphokine-activated killer activity in rodents but not in humans is nitric oxide dependent. Cell. Immunol. 157, 462-477.
17. Kopf, M., Brombacher, F., Köhler, G., Kienzle, G., Widmann, K.-H., Lefrang, K., Humborg, C., Ledermann, B., and Solbach, W. (1996). IL-4 deficient BALB/c mice resist infection with Leishmania major. J. Exp. Med. 184, 1127-1136.
18. Lander, H.M., Sehajpal, P.K., and Novogrodsky, A. (1993). Nitric oxide signaling: a possible role for G proteins. J. Immunol. 151, 7182-7187.
19. Laskay,T., Röllinghoff, M.,and Solbach, W. (1993). Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur. J. Immunol. 23, 2237-2241.
20. Laskay, T., Diefenbach, A., Röllinghoff, M., and Solbach, W. (1995). Early parasite containment is decisive for resistance to Leishmania major infection. Eur. J. Immunol. 25, 2220-2227.
21. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6, 541-549.
22. Liew, F.Y., Millott, S., Parkinson, C., Palmer, R.M.J., and Moncada, S. (1990). Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144, 4794-4797.
23. Lohoff, M., Ferrick, D., Mittrücker, H.-W., Duncan, G.S., Bischof, S., Röllinghoff, M., and Mak, T.W. (1997). Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6, 681-689.
24. MacMicking, J., Xie, Q.-w., and Nathan, C. (1997a). Nitric oxide and macrophage function. Ann. Rev. Immunol. 15, 323-350.
25. MacMicking, J.D., North, R.J., LaCourse, R., Mudgett, J.S., Shah, S.K., and Nathan, C.F. (1997b). Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94, 5243-5248.
26. Magrinat, G., Mason, S.N., Shami, P.J., and Weinberg, J.B. (1992). Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood 1992, 1880-1884.
27. Marcinkiewicz, J., Grabowska, A., and Chain, B. (1995). Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol. 25, 947-951.
28. Martin, E., Nathan, C., and Xie, Q.-w. (1994). Role of interferon regulatory factor-1 in induction of nitric oxide synthase. J. Exp. Med. 180, 977-984.
29. Nakane, A., Minagawa, T., and Yasuda, I. (1985). Induction of alpha/ beta interferon and gamma interferon in mice infected with Listeria monocytogenes during pregnancy. Infect. Immun. 50, 877-880.
30. Noble, P.W., Henson, P.M., Lucas, C., Mora-Worms, M., Carré, P.C., and Riches, D.W.H. (1993). Transforming growth factor-β primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine/paracrine mechanism. J. Immunol. 151, 979-989.
31. Peng, H.-B., Libby, P., and Liao, J.K. (1995). Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J. Biol. Chem. 270, 14214-14219.
32. Pilz, R.B., Suhasini, M., Idriss, S., Meinkoth, J.L., and Boss, G.R. (1995). Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J. 9, 552-558.
33. Platzer, C., Richter, G., ψberla, K., Müller, W., Blöcker, H., Diamantstein, T., and Blankenstein, T. (1992). Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase-chain-reaction. Eur. J. Immunol. 22, 1179-1184.
34. Reiner, S.L., and Locksley, R.M. (1995). The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13, 151-177.
35. Reiner, S.L., Zheng, S., Wang, Z.-E., Stowring, L., and Locksley, R.M. (1994). Leishmania promastigotes evade interleukin 12(IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J. Exp. Med. 179, 447-456.
36. Reis, L.F.L., Harada, H., Wolchok, J.D., Taniguchi, T., and Vilcek, J. (1992). Critical role of a common transcription factor, IRF-1, in the regulation of IFN-β and IFN-inducible genes. EMBO J. 11, 185-193.
37. Remick, D.G., and Villarete, L. (1996). Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates. J. Leukoc. Biol. 59, 471-475.
38. Rook, A.H., Kehrl, J.H., Wakefield, L.M., Roberts, A.B., Sporn, M.B., Burlington, D.B., Lane, H.C., and Fauci, A.S. (1986). Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136, 3916-3920.
39. Scharton, T.M., and Scott, P. (1993). Natural killer cells are a source of IFN-γ that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178, 567-578.
40. Scharton-Kersten, T.M., and Sher, A. (1997). Role of natural killer cells in innate resistance to protozoan infections. Curr. Opin. Immunol. 9, 44-51.
41. Scharton-Kersten, T.M., Yap, G., Magram, J., and Sher, A. (1997). Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185, 1261-1273.
42. Shankar, A.H., Morin, P., and Titus, R.G. (1996). Leishmania major: differential resistance to infection in C57BL/6 (high interferon-α/β) and congenic B6. C-H-28c (low interferon-α/β) mice. Exp. Parasitol. 84, 136-143.
43. Stenger, S., Thüring, H., Röllinghoff, M., and Bogdan, C. (1994). Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180, 783-793.
44. G-monomethyl-arginine in vitro and in vivo. Eur. J. Pharmacol. 294, 703-712.
45. Stenger, S., Donhauser, N., Thüring, H., Röllinghoff, M., and Bogdan, C. (1996). Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183, 1501-1514.
46. Taki, S., Sato, T., Ogasawara, K., Fukuda, T., Sato, M., Hida, S., Suzuki, G., Mitsuyama, M., Shin, E.-H., Kojima, S., et al. (1997). Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6, 673-679.
47. Wei, X.-q., Charles, I.G., Smith, A., Ure, J., Feng, G.-J., Huang, F.-P., Xu, D., Müller, W., Moncada, S., and Liew, F.Y. (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411.